Karam Khaddour

821 total citations
47 papers, 542 citations indexed

About

Karam Khaddour is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karam Khaddour has authored 47 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karam Khaddour's work include Cancer Immunotherapy and Biomarkers (11 papers), Glioma Diagnosis and Treatment (8 papers) and CAR-T cell therapy research (6 papers). Karam Khaddour is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Glioma Diagnosis and Treatment (8 papers) and CAR-T cell therapy research (6 papers). Karam Khaddour collaborates with scholars based in United States, Russia and Syria. Karam Khaddour's co-authors include George Ansstas, Tanner M. Johanns, Yanis Boumber, Jyoti D. Patel, Jiayi Huang, Sonika Dahiya, Farrokh Dehdashti, Michael Ansstas, Oleg I. Kit and Hossein Borghaei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and CHEST Journal.

In The Last Decade

Karam Khaddour

43 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karam Khaddour United States	14	200	160	141	91	78	47	542
Wenyu Li China	15	275 1.4×	196 1.2×	81 0.6×	60 0.7×	89 1.1×	81	738
Afshin Moradi Iran	14	183 0.9×	216 1.4×	113 0.8×	122 1.3×	100 1.3×	79	640
Yu Oyama Japan	15	171 0.9×	106 0.7×	80 0.6×	106 1.2×	34 0.4×	41	753
Teresa Caballero‐Velázquez Spain	15	173 0.9×	279 1.7×	170 1.2×	72 0.8×	40 0.5×	53	892
Marie V. Daugan France	6	150 0.8×	246 1.5×	70 0.5×	61 0.7×	61 0.8×	8	589
Ik‐Chan Song South Korea	17	208 1.0×	236 1.5×	97 0.7×	80 0.9×	89 1.1×	87	720
Yanxia Zhan China	17	84 0.4×	230 1.4×	85 0.6×	49 0.5×	152 1.9×	54	743
Yasushi Otani Japan	10	383 1.9×	149 0.9×	78 0.6×	171 1.9×	29 0.4×	19	607
Liang Peng China	16	251 1.3×	310 1.9×	39 0.3×	123 1.4×	149 1.9×	78	843
Tim N. Beck United States	14	298 1.5×	352 2.2×	48 0.3×	114 1.3×	151 1.9×	28	756

Countries citing papers authored by Karam Khaddour

Since Specialization

Citations

This map shows the geographic impact of Karam Khaddour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karam Khaddour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karam Khaddour more than expected).

Fields of papers citing papers by Karam Khaddour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karam Khaddour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karam Khaddour. The network helps show where Karam Khaddour may publish in the future.

Co-authorship network of co-authors of Karam Khaddour

This figure shows the co-authorship network connecting the top 25 collaborators of Karam Khaddour. A scholar is included among the top collaborators of Karam Khaddour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karam Khaddour. Karam Khaddour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Emily, et al.. (2024). Patterns of initial distant metastases in 151 patients undergoing surveillance for treated Merkel cell carcinoma. Journal of the European Academy of Dermatology and Venereology. 38(6). 1202–1212. 2 indexed citations

Khaddour, Karam, Rizwan Haq, Elizabeth I. Buchbinder, et al.. (2024). Targeting RAF1 gene fusions with MEK inhibition in metastatic melanoma. The Oncologist. 30(3).

Khaddour, Karam, et al.. (2024). Survival outcomes in patients with de novo metastatic Merkel cell carcinoma according to site of metastases. Frontiers in Oncology. 14. 1444590–1444590. 1 indexed citations

Zhou, Alice Y., et al.. (2024). Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma. Frontiers in Oncology. 14. 1385094–1385094. 2 indexed citations

Khaddour, Karam, Naoka Murakami, Emily S. Ruiz, & Ann W. Silk. (2024). Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression. Cancers. 16(17). 3083–3083. 5 indexed citations

Zhou, Alice Y., et al.. (2023). Determining PARP Inhibition as a Treatment Strategy in Melanoma Based on Homologous Recombination Deficiency–Related Loss of Heterozygosity. Journal of the National Comprehensive Cancer Network. 21(7). 688–693.e3. 8 indexed citations

Khaddour, Karam, et al.. (2023). Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma. Frontiers in Oncology. 13. 1276729–1276729. 4 indexed citations

Hwang, Helen, Jiayi Huang, Karam Khaddour, et al.. (2022). Prolonged response of recurrent IDH -wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab. CNS Oncology. 11(1). 23 indexed citations

Khaddour, Karam, et al.. (2022). Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios. Frontiers in Oncology. 12. 978996–978996. 6 indexed citations

10.

Khaddour, Karam, et al.. (2022). The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer. Cancers. 14(21). 5305–5305. 6 indexed citations

11.

Khaddour, Karam, Sushma Jonna, Alexander Y. Deneka, et al.. (2021). Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies. Cancers. 13(13). 3164–3164. 44 indexed citations

12.

Khaddour, Karam, Michael R. Chicoine, Jiayi Huang, Sonika Dahiya, & George Ansstas. (2020). Successful Use of BRAF/MEK Inhibitors as a Neoadjuvant Approach in the Definitive Treatment of Papillary Craniopharyngioma. Journal of the National Comprehensive Cancer Network. 18(12). 1590–1595. 28 indexed citations

13.

Khaddour, Karam, Emily S. Gorell, Farrokh Dehdashti, Jean Y. Tang, & George Ansstas. (2020). Induced Remission of Metastatic Squamous Cell Carcinoma with an Immune Checkpoint Inhibitor in a Patient with Recessive Dystrophic Epidermolysis Bullosa. Case Reports in Oncology. 13(2). 911–915. 18 indexed citations

14.

Khaddour, Karam, Sandra L. Gomez‐Perez, Nikita Jain, Jyoti D. Patel, & Yanis Boumber. (2020). Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors. Frontiers in Oncology. 10. 576314–576314. 20 indexed citations

15.

Jain, Nikita, et al.. (2020). Delayed Recurrence of Chromophobe Renal Cell Carcinoma Presenting as Metastatic Duodenal Ulcer. Cureus. 12(7). e9154–e9154. 1 indexed citations

16.

Khaddour, Karam, et al.. (2019). Thrombotic Thrombocytopenic Purpura Evaluation and Management. StatPearls. 16 indexed citations

17.

Gerriets, Valerie A., et al.. (2019). Tumor Necrosis Factor (TNF) Inhibitors. StatPearls. 13 indexed citations

18.

Limaïem, Faten, James W. Kühn, & Karam Khaddour. (2019). Cancer, Telangiectatic Osteosarcoma. StatPearls. 1 indexed citations

19.

Khaddour, Karam, et al.. (2019). Characteristics of clear cell renal cell carcinoma metastases to the thyroid gland: A systematic review. World Journal of Clinical Cases. 7(21). 3474–3485. 16 indexed citations

20.

Gerriets, Valerie A., Pankaj Bansal, Amandeep Goyal, & Karam Khaddour. (2018). Tumor Necrosis Factor Inhibitors. StatPearls. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact